DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Hydralazine hydrochloride; hydrochlorothiazideis the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-one drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.
Recent Clinical Trials for hydralazine hydrochloride; hydrochlorothiazide
Identify potential brand extensions & 505(b)(2) entrants
|Vanderbilt University Medical Center||Phase 4|
|National Center for Research Resources (NCRR)||Phase 4|
|Vanderbilt University Medical Center||Phase 1/Phase 2|